Democratising Precision Medicine

The dawn of precision medicine has revolutionised the way we understand and treat diseases, particularly in oncology and rare diseases. Within this rapidly evolving field, MGI stands at the forefront, pioneering innovative approaches to empower research communities to unlock the mysteries of human genetics and harnessing this knowledge to drive personalised therapies. By dropping the price of genome sequencing to sub $100, MGI has not only democratised access to comprehensive genomic information but has also catalysed transformative progress in precision oncology and rare disease research. With affordable high-throughput sequencing technology, scientists can accelerate the pace of discovery, unravelling the complexities of diseases with unprecedented precision and efficiency. Download the whitepaper for the full details.